Stock 6598 APPLIED BIOCODE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E.
Other stock markets
 23:00:00 19/05/2024 BST 		5-day change 1st Jan Change
20.9 TWD -0.71% Intraday chart for Applied BioCode Corporation +5.03% -17.39%
04-15 Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only CI
03-21 Applied BioCode Announces CEO Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
Applied BioCode Announces CEO Changes
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Applied BioCode Corporation Announces the Change of Representative of Institutional Director
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer
Applied BioCode Corporation Announces Resignation of Craig Griz Adams as Sales Director
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Applied Biocode Corporation Announces the Change of Sales Director
Applied BioCode Corporation Announces the Change of Vice President of Operation
Applied BioCode Corporation Announces Change of Sales Director
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6598 Stock
  4. News Applied BioCode Corporation
  5. Other languages